Elevance Health (ELV) FY26 Adj. EPS view maintained at 25.50 (exp. 26.05); announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits.

• Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon.
• Felicia Norwood, Executive Vice President and Chief Health Benefits Officer, will assume responsibility for the Company’s consolidated Health Benefits organization.
• Peter D. Haytaian has announced that he will transition from his role as Executive Vice President and President of Carelon effective May 4, 2026, in order to devote more time to family commitments.

Elevance Health has maintained its FY26 adjusted EPS view slightly below expectations, which could suggest a cautious outlook from management. The announced changes in leadership aimed at streamlining operations might indicate a strategic pivot towards improving execution, pivotal for investor confidence. Watch for potential market reactions as this could impact the stock’s performance relative to peers in the health care sector.